FUNCTIONAL AREAS – Page 82

Compliance gaps not escalated during mock audit – preventing repeat observations

Understanding the signs of compliance gaps is the first step in remediation. Symptoms may present themselves in various forms within the laboratory or manufacturing environments. These can include:Click to read…

Inspection readiness untested during enforcement response – how to satisfy FDA/EMA expectations

The initial indicators of potential issues related to inspection readiness often manifest as deviations, out-of-specification (OOS) results, or complaints. These symptoms may include:Click to read the full article.

Internal audit findings ignored during remediation – CAPA program design

Identifying the symptoms of ignored internal audit findings is crucial for understanding the underlying issues. Common signals that may suggest audit findings are not being addressed effectively include:Click to read…

Compliance gaps not escalated during corporate review – preventing repeat observations

The first step in addressing compliance gaps is recognizing the symptoms or signals that suggest something is amiss during corporate audits or reviews. Common indicators include:Click to read the full…

Inspection readiness untested during enforcement response – enforcement risk and mitigation plan

Recognizing early warning signs is crucial for mitigating inspection risks. Various symptoms may manifest both on the production floor and in laboratory settings, indicating potential compliance issues, such as:Click to…

Internal audit findings ignored during corporate review – CAPA program design

Identifying the signs that indicate audit findings are being ignored is crucial for timely action. Symptoms can manifest in several areas within the organization:Click to read the full article.

Compliance gaps not escalated during enforcement response – CAPA program design

The first step in addressing compliance gaps not escalated during enforcement response is to observe and document the various symptoms or signals that indicate a potential problem. Symptoms can manifest…

Complete Guide to Stability Studies in Pharmaceutical Development

Identifying the signs of instability during stability studies is crucial for ensuring product quality. Symptoms may manifest during routine testing or through unexpected deviations during stability testing.Click to read the…

How to Design Stability Studies for Drug Products and APIs

Step-by-Step Guide to Designing and Implementing Stability Studies for Drug Products and APIs Stability studies play a critical role in ensuring the quality and efficacy of drug products and active…

Real-Time vs Accelerated Stability Studies Explained Practically

Identifying symptoms related to stability studies is the first step in troubleshooting potential issues. Common signals of instability can include:Click to read the full article.

How to Prepare a Stability Protocol for Regulatory Submission

Typically, the signs indicating a need for a stability protocol include discrepancies observed during product testing, unexpected degradation, and variations in potency. Here are common symptoms to watch for:Click to…

Stability Study Time Points and Pull Schedule Planning

When planning stability studies, specific symptoms can indicate potential issues in your time points or pull schedules:Click to read the full article.